| 1 |
赵思俊，李雪莲，曹旭敏，等. 肉毒杆菌及肉毒毒素研究进展[J]. 中国动物检疫，2013(8):36-39.
|
| 2 |
Drinovac V, Bach-Rojecky L, Babic A, et al. Antinociceptive effect of botulinum toxin type A on experimental abdominal pain[J]. Eur J Pharmacol, 2014, 745:190-195.
|
| 3 |
Marino MJ, Terashima T, Steinauer JJ, et al. Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior[J]. Pain, 2014, 155(4):674-684.
|
| 4 |
石磊. A型肉毒毒素去除面上部动力性皱纹30例[J]. 长江大学学报(自科版), 2016, 13(12):51-52.
|
| 5 |
万彬彬，张平. 不同浓度A型肉毒毒素治疗上面部动力性皱纹的疗效分析[J]. 中国美容医学，2016, 25(8):20-21.
|
| 6 |
Wanitphakdeedecha R, Ungaksornpairote C, Kaewkes A, et al. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face－lifting: a split－face randomized controlled trial[J]. Cosmet Dermatol, 2016, 15(4):452-457.
|
| 7 |
马晓荣，张英，张璐，等. 不同方法治疗后咬肌厚度减少的比较研究[J]. 中国美容整形外科杂志，2008, 19(4):218-220.
|
| 8 |
潘盛盛，倪彬婷，李力群. A型肉毒毒素连续注射和单次注射矫正咬肌肥大的效果比较[J]. 中华全科医学，2016, 14(10):1616-1618.
|
| 9 |
齐琦. A型肉毒素局部注射治疗腋臭21例疗效观察[J]. 中国医疗美容，2016, 6(5):7-9.
|
| 10 |
Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial[J]. BMJ, 2011, 323(7313):596-599.
|
| 11 |
Glaser DA, Pariser DM, Hebert AA, et al. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis[J]. Pediatr Dermatol, 2015, 32(5):609-617.
|
| 12 |
Gibbons JP, Nugent E, O′Donohoe N, et al. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy－A quality of life and cost effectiveness analysis[J]. Surgeon, 2016, 14(5):260-264.
|
| 13 |
王琳，邰宁正，傅敏刚，等. A型肉毒素注射治疗瘢痕疙瘩顽固性痛痒的临床研究[J]. 组织工程与重建外科，2009, 5(5):286-288.
|
| 14 |
Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial[J]. J Cosmet Dermatol, 2015, 14(2):161-166.
|
| 15 |
李正斌，梁俊刚，路光辉. A型肉毒毒素在面部整形美容手术切口愈合中的应用研究[J]. 系统医学，2016(1):17-19.
|
| 16 |
王长慧，魏翠娥，孙娆，等. A型肉毒毒素联合减张压迫法在面部整形美容切口中的应用[J]. 中国美容医学，2011, 20(3):359-361.
|
| 17 |
吴铁娟. 观察A型肉毒毒素联合减张压迫法在面部整形美容切口中的应用效果[J]. 中国医疗美容，2014(6):7.
|
| 18 |
李卫华，高玉伟，李德水，等. A型肉毒毒素引起人增生性瘢痕成纤维细胞的凋亡[J]. 中国组织工程研究，2013, 17(24):4429-4435.
|
| 19 |
Choe WJ, Kim J. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm[J]. Acta Otolaryngol, 2016, 136(9):952-955.
|
| 20 |
刘剑英，苏智勇，王涛，等. A型肉毒素局部注射治疗单纯性面肌痉挛的疗效分析[J]. 中国医疗美容，2016, 6(2):43-44.
|
| 21 |
罗丽华，王康，韩燕飞，等. 良性特发性眼睑痉挛的研究进展[J]. 国际眼科杂志，2016, 16(10):1855-1857.
|
| 22 |
赵敏，孙重. 两种不同浓度的A型肉毒素注射治疗眼睑痉挛的观察对比[J]. 国际眼科杂志，2016, 16(8):1587-1589.
|
| 23 |
Isshiki Y, Ishikawa H, Mimura O. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm[J]. Jpn J Ophthalmol, 2016, 60(6):486-491.
|
| 24 |
吴溯帆. 注射美容整形技术[M]. 杭州：杭州科学技术出版社，2015:167-169.
|
| 25 |
刘春明，刘芸. A型肉毒毒素治疗痉挛型脑瘫的研究进展[J]. 中国民康医学，2015(17):65-68.
|
| 26 |
张艳娇. 超声定位引导A型肉毒毒素注射联合常规康复训练治疗痉挛型脑瘫的疗效观察[D]. 安徽医科大学，2016.
|
| 27 |
陈海. A型肉毒毒素在脑瘫患儿康复治疗中的效果评价[J]. 中国现代药物应用，2016, 10(13):187-189.
|
| 28 |
Dursun N, Gokbel T, Akarsu M, et al. A Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment[J]. Am J Phys Med Rehabil, 2017, 96(4):221-225.
|
| 29 |
Kahraman A, Seyhan K, Deger Ü，et al. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review[J]. Dev Med Child Neurol, 2016, 58(9):910-917.
|
| 30 |
Montastruc J, Marque P, Moulis F, et al. Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase[J]. Dev Med Child Neuro, 2017, 59(3):329-334.
|
| 31 |
Loder E, Rizzoli P. Tension-type headache[J]. BMJ, 2008, 336(7635):88-92.
|
| 32 |
唐修明，崔超伟，刘强，等. A型肉毒毒素治疗紧张性头痛的血流动力学研究[C]. 华北地区神经病学学术会议暨2013年北京地区神经病学学术年会，2013.
|
| 33 |
胡悦育，胡兴越. A型肉毒毒素治疗偏头痛的临床研究[J]. 中国新药与临床杂志，2005, 24(2):165-168.
|
| 34 |
成爱霞. 两种不同剂量A型肉毒毒素治疗偏头痛的疗效观察[J]. 中国实用医药，2012, 7(6):162-163.
|
| 35 |
Blumenfeld A. Clinical approaches to migraine prophylaxis[J]. Am J Manag Care, 2005, 11(2 Suppl):55-61.
|
| 36 |
Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root neurons to Clostridium botulinum neurotoxins[J]. Toxicon, 2000, 38(2):245-258.
|
| 37 |
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management[J]. Headache, 2003, 43(43 Suppl 1):S9-S15.
|
| 38 |
Patil S, Willett O, Thompkins T, et al. Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States[J]. Curr Pain Headache Rep, 2016, 20(3):15.
|
| 39 |
Ghasemi M, Salari M, Khorvash F, et al. A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity[J]. Int J Prev Med, 2013, 4(Suppl 2):S147-S158.
|
| 40 |
中国康复医学会. 肉毒毒素治疗成人肢体痉挛状态中国指南(2015)[J]. 中国康复医学杂志，2015, 30(1):595-620.
|
| 41 |
Lungren MP, Halula S, Coyne S, et al. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital[J]. Pediatr Neurol, 2016, 54:70-75.
|
| 42 |
Ciftci T, Akinci D, Yurttutan N, et al. US-guided botulinum toxin injection for excessive drooling in children[J]. Diagn Interv Radiol, 2013, 19(1):56-60.
|
| 43 |
Basciani M, Di Rienzo F, Fontana A, et al. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses[J]. Dev Med Child Neurol, 2011, 53(6):559-564.
|
| 44 |
Jenkins SN, Neyman KM, Veledar E, et al. A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon[J]. J Am Acad Dermatol, 2013, 69(5):834-835.
|
| 45 |
Zhang X, Hu Y, Nie Z, et al. Treatment of Raynaud’s phenomenon with botulinum toxin type A[J]. Neurol Sci, 2015, 36(7):1225-1231.
|
| 46 |
Park TH. Letter regarding "the effect of botulinum neurotoxin-a on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon"[J]. J Hand Surg Am, 2012, 37(5):1104-1105.
|
| 47 |
Pinto R, Lopes T, Costa D, et al. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A[J]. Urology, 2014, 83(5):1030-1034.
|
| 48 |
Kuo HC. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.[J]. Int J Clin Pract, 2013, 67(5):427-434.
|
| 49 |
李杰荣，刘国庆，王剑锋，等. A型肉毒毒素注射治疗女性间质性膀胱炎/膀胱疼痛综合征的效果[J]. 广东医学，2015, 36(24):3853-3856.
|
| 50 |
Shahani R, Streutker C, Dickson B, et al. Ketamine-associated ulcerative cystitis: a new clinical entity[J]. Urology, 2007, 69(5):810-812.
|
| 51 |
陈剑，唐华，魏怀莹，等. 膀胱内注射肉毒素A治疗氯胺酮相关性膀胱功能障碍28例临床研究[J]. 福建医药杂志，2015, 37(3):11-14.
|
| 52 |
刘欣健，文建国，万有栋，等. 膀胱不同部位注射肉毒素A治疗难治性膀胱过度活动症的Meta分析[J]. 现代泌尿外科杂志，2015, 20(8):541-546.
|
| 53 |
Weglinski L, Haddad R, Peyronnet B, et al. Efficacy and safety of a first intradetrusorial injection of botulinum toxin-A for the treatment of refractory overactive bladder in 54 elderly patients[J]. Ann Phys Rehabil Med, 2016, 59:e104-e105.
|
| 54 |
徐其涛，罗娜，姜俊海，等. 肉毒素A治疗神经源性膀胱过度活动症的系统评价[J]. 现代泌尿外科杂志，2015(4):218-224.
|
| 55 |
Maria G, Brisinda G, Civello IM, et al. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study[J]. Urology, 2003, 62(2):259-264.
|
| 56 |
Kuo HC, Liu HT. Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy[J]. Scand J Urol, 2009, 43(3):206-211.
|
| 57 |
Brisinda G, Cadeddu F, Vanella S, et al. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results[J]. Urology, 2009, 73(1):90-94.
|
| 58 |
McVary KT, Roehrborn CG, Chartier-Kastler E, et al. A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia[J]. J Urol, 2014, 192(1):150-156.
|
| 59 |
Marberger M, Chartier-Kastler E, Egerdie B, et al. A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia.[J]. Eur Urol, 2013, 63(3):496-503.
|
| 60 |
Mostachio GQ, Apparício M, Motheo TF, et al. Intra-prostatic injection of botulinum toxin type A in treatment of dogs with spontaneous benign prostatic hyperplasia[J]. Anim Reprod Sci, 2012, 133(3/4):224-228.
|
| 61 |
Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin[J]. Pharmacology, 2015, 95(1/2):65-69.
|